SEEL logo

Seelos Therapeutics (SEEL) Total Expenses

Annual Total Expenses

$40.50 M
-$30.42 M-42.89%

December 31, 2023

Summary

Performance

1-Year Change

-42.89%

3-Year Change

+115.89%

5-Year Change

+342.71%

15-Year Change

+279.45%

SEEL Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.11%
SEEL annual total expenses is higher than 34.11% of companies in Healthcare sector

High & Low

All-time High

$70.92 M
SEEL annual total expenses is currently -42.89% below its historical high of $70.92 million

3-Year Low

$40.50 M
SEEL annual total expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SEEL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
SEEL next annual earnings announcement has not yet been scheduled

OtherSEELexpensesmetrics:

Annual Interest Expense

$75.00 K
SEEL annual interest expense is $75.00 thousand

Annual Income Tax

-
SEEL annual income tax value is unknown

Annual Operating Expenses

$40.50 M
SEEL annual total operating expenses is $40.50 million

Annual Cost Of Goods Sold

-
SEEL annual cost of goods sold value is unknown

Quarterly Total Expenses

$3.14 M
-$2.92 M-48.16%

June 30, 2024

Summary

Performance

3-Month Change

-48.16%

1-Year Change

-75.09%

3-Year Change

-82.81%

5-Year Change

-7.51%

SEEL Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.23%
SEEL quarterly total expenses is higher than 13.23% of companies in Healthcare sector

High & Low

All-time High

$27.37 M
SEEL quarterly total expenses is currently -88.53% below its historical high of $27.37 million

3-Year Low

$3.14 M
SEEL quarterly total expenses is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELexpensesmetrics:

Quarterly Interest Expense

$23.00 K
SEEL quarterly interest expense is $23.00 thousand

Quarterly Income Tax

-
SEEL quarterly income tax value is unknown

Quarterly Operating Expenses

$3.14 M
SEEL quarterly total operating expenses is $3.14 million

Quarterly Cost Of Goods Sold

-
SEEL quarterly cost of goods sold value is unknown

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual Total Expenses

$40.50 M
SEEL annual total expenses is $40.50 million

Annual Cost Of Goods Sold

-
SEEL annual cost of goods sold value is unknown

Annual Operating Expenses

$40.50 M
SEEL annual total operating expenses is $40.50 million

SEEL Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-42.9%-75.1%
3 y3 years+115.9%-82.8%
5 y5 years+342.7%-7.5%

SEEL Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-42.9%at low-88.5%at low
5 y5-year-42.9%+115.9%-88.5%at low
alltimeall time-42.9%+937.5%-88.5%+201.7%

Seelos Therapeutics Total Expenses History

DateAnnualQuarterly
Jun 2024
-
$3.14 M(-48.2%)
Mar 2024
-
$6.05 M(-24.4%)
Dec 2023
$40.50 M(-42.9%)
$8.01 M(-36.4%)
Sep 2023
-
$12.60 M(+15.1%)
Jun 2023
-
$10.95 M(+22.6%)
Mar 2023
-
$8.93 M(-51.1%)
Dec 2022
$70.92 M(+15.0%)
$18.26 M(+4.9%)
Sep 2022
-
$17.41 M(-18.0%)
Jun 2022
-
$21.24 M(+51.6%)
Mar 2022
-
$14.01 M(-48.8%)
Dec 2021
$61.67 M(+228.7%)
$27.37 M(+150.9%)
Sep 2021
-
$10.91 M(+61.1%)
Jun 2021
-
$6.77 M(-59.2%)
Mar 2021
-
$16.61 M(+184.2%)
Dec 2020
$18.76 M(-36.9%)
$5.84 M(+43.1%)
Sep 2020
-
$4.08 M(+23.0%)
Jun 2020
-
$3.32 M(-39.7%)
Mar 2020
-
$5.51 M(-46.7%)
Dec 2019
$29.75 M(+225.2%)
$10.33 M(+180.6%)
Sep 2019
-
$3.68 M(+8.5%)
Jun 2019
-
$3.39 M(-72.5%)
Mar 2019
-
$12.34 M(+76.2%)
Dec 2018
$9.15 M(-14.3%)
$7.00 M(+544.3%)
Sep 2018
-
$1.09 M(-51.4%)
Jun 2018
-
$2.24 M(-4.9%)
Mar 2018
-
$2.35 M(-11.2%)
Dec 2017
$10.67 M(-21.9%)
$2.65 M(-28.7%)
Sep 2017
-
$3.72 M(+52.2%)
Jun 2017
-
$2.44 M(+31.7%)
Mar 2017
-
$1.85 M(-26.1%)
Dec 2016
$13.66 M(-47.6%)
$2.51 M(+45.7%)
Sep 2016
-
$1.72 M(-62.8%)
Jun 2016
-
$4.63 M(-4.2%)
Mar 2016
-
$4.83 M(-20.1%)
Dec 2015
$26.09 M(-22.4%)
$6.04 M(-15.7%)
Sep 2015
-
$7.17 M(+14.0%)
Jun 2015
-
$6.29 M(-4.7%)
Mar 2015
-
$6.60 M(-65.3%)
Dec 2014
$33.62 M(+57.8%)
$18.99 M(+273.7%)
Sep 2014
-
$5.08 M(+0.5%)
Jun 2014
-
$5.05 M(+12.3%)
Mar 2014
-
$4.50 M(+1.7%)
Dec 2013
$21.31 M(-14.6%)
$4.43 M(+16.5%)
Sep 2013
-
$3.80 M(-36.6%)
Jun 2013
-
$5.99 M(-15.5%)
Mar 2013
-
$7.09 M(-19.8%)
Dec 2012
$24.95 M(+33.8%)
$8.84 M(+20.4%)
Sep 2012
-
$7.34 M(+68.9%)
Jun 2012
-
$4.35 M(-3.2%)
Mar 2012
-
$4.49 M(+279.9%)
DateAnnualQuarterly
Dec 2011
$18.65 M(+15.1%)
$1.18 M(-60.9%)
Sep 2011
-
$3.03 M(-67.9%)
Jun 2011
-
$9.43 M(+88.1%)
Mar 2011
-
$5.01 M(+6.1%)
Dec 2010
$16.21 M(+161.0%)
$4.72 M(+29.8%)
Sep 2010
-
$3.64 M(-12.1%)
Jun 2010
-
$4.14 M(+11.8%)
Mar 2010
-
$3.70 M(+78.1%)
Dec 2009
$6.21 M(-44.2%)
$2.08 M(+103.1%)
Sep 2009
-
$1.02 M(-27.4%)
Jun 2009
-
$1.41 M(-16.7%)
Mar 2009
-
$1.69 M(-46.5%)
Dec 2008
$11.13 M(+4.4%)
$3.17 M(-1.1%)
Sep 2008
-
$3.20 M(+39.9%)
Jun 2008
-
$2.29 M(-7.4%)
Mar 2008
-
$2.47 M(-34.7%)
Dec 2007
$10.66 M(-3.1%)
$3.78 M(+64.2%)
Sep 2007
-
$2.30 M(+2.0%)
Jun 2007
-
$2.26 M(-2.3%)
Mar 2007
-
$2.31 M(-25.0%)
Dec 2006
$11.00 M(-39.3%)
$3.08 M(+27.8%)
Sep 2006
-
$2.41 M(+11.6%)
Jun 2006
-
$2.16 M(-35.3%)
Mar 2006
-
$3.34 M(-45.0%)
Dec 2005
$18.10 M(+2.5%)
$6.07 M(+93.4%)
Sep 2005
-
$3.14 M(-27.5%)
Jun 2005
-
$4.33 M(-5.2%)
Mar 2005
-
$4.57 M(-3.6%)
Dec 2004
$17.66 M(+23.2%)
$4.74 M(+0.9%)
Sep 2004
-
$4.70 M(+10.9%)
Jun 2004
-
$4.23 M(+6.0%)
Mar 2004
-
$3.99 M(-18.8%)
Dec 2003
$14.34 M(-48.2%)
$4.92 M(+69.0%)
Sep 2003
-
$2.91 M(-14.7%)
Jun 2003
-
$3.41 M(-210.6%)
Mar 2003
-
-$3.09 M(-137.4%)
Dec 2002
$27.71 M(+60.4%)
$8.26 M(+21.1%)
Sep 2002
-
$6.82 M(-1.8%)
Jun 2002
-
$6.95 M(+22.2%)
Mar 2002
-
$5.68 M(-7.3%)
Dec 2001
$17.27 M(+71.0%)
$6.13 M(+66.7%)
Sep 2001
-
$3.68 M(-3.5%)
Jun 2001
-
$3.81 M(+4.5%)
Mar 2001
-
$3.65 M(-2.4%)
Dec 2000
$10.10 M(+82.0%)
$3.74 M(+59.6%)
Sep 2000
-
$2.34 M(-10.5%)
Jun 2000
-
$2.62 M(+86.0%)
Mar 2000
-
$1.41 M
Dec 1999
$5.55 M(+42.2%)
-
Dec 1997
$3.90 M
-

FAQ

  • What is Seelos Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Seelos Therapeutics?
  • What is Seelos Therapeutics annual total expenses year-on-year change?
  • What is Seelos Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly total expenses year-on-year change?

What is Seelos Therapeutics annual total expenses?

The current annual total expenses of SEEL is $40.50 M

What is the all time high annual total expenses for Seelos Therapeutics?

Seelos Therapeutics all-time high annual total expenses is $70.92 M

What is Seelos Therapeutics annual total expenses year-on-year change?

Over the past year, SEEL annual total expenses has changed by -$30.42 M (-42.89%)

What is Seelos Therapeutics quarterly total expenses?

The current quarterly total expenses of SEEL is $3.14 M

What is the all time high quarterly total expenses for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly total expenses is $27.37 M

What is Seelos Therapeutics quarterly total expenses year-on-year change?

Over the past year, SEEL quarterly total expenses has changed by -$9.46 M (-75.09%)